Reclassification of marijuana opens doors for much-needed medical research … – The Conversation
The DEA's proposed reclassification of cannabis from Schedule I to Schedule III represents a watershed moment for medical research opportunities in cannabis medicine. This regulatory shift will remove decades-old barriers to rigorous clinical studies…
Trinity County bans industrial hemp to protect licensed cannabis growers – MMJDaily
Trinity County's decision to ban industrial hemp to protect licensed cannabis operations demonstrates how hemp ban affects medical cannabis patient access. This regulatory approach aims to prevent cross-pollination that could reduce therapeutic cannabis…
Mounjaro Counterfeit Seizure: GLP-1 Clinical Supply Chain Risks
GLP-1 Clinical Relevance #41Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic NewsSupply Chain InvestigationType 2 DiabetesTirzepatideRegulatory AffairsGlobal Patient PopulationDrug…
Characterizing public comments via Regulations.gov in response to proposed cannabis rescheduling in the United States.
The United States Drug Enforcement Administration's (DEA) proposed rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances A...
Potential Trump psychedelic order could reshape cannabis industry – MMJDaily
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyPsychedelicsRegulatory AffairsFederal…
Bring It On: Meet the Cannabis CMO Welcoming Scrutiny With Open Arms
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Industry StandardsClinical EvidenceProduct…
Med cannabis sales plunge | Pharmacy Daily
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic AccessHealthcare EconomicsPatient…
Hemp businesses in Mass. unclear on future as federal ban looms – The Boston Globe
✦ New CED Clinical Relevance #82High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Hemp PolicyRegulatory AffairsPatient…
Regulating Payment of Participant Data in Clinical Trials | The Regulatory Review
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Clinical ResearchHealthcare…
Editorial: Weed tax confusion is budget ‘deadline’ hangover – Crain’s Detroit Business
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyPatient AccessHealthcare…